Abrogation of Src Homology Region 2 Domain-Containing Phosphatase 1 in Tumor-Specific T Cells Improves Efficacy of Adoptive Immunotherapy by Enhancing the Effector Function and Accumulation of Short-Lived Effector T Cells In Vivo-Reference-Cited by-同舟云学术

Abrogation of Src Homology Region 2 Domain-Containing Phosphatase 1 in Tumor-Specific T Cells Improves Efficacy of Adoptive Immunotherapy by Enhancing the Effector Function and Accumulation of Short-Lived Effector T Cells In Vivo

Published:2012-07-13 Issue:4 Volume:189 Page:1812-1825
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Stromnes Ingunn M.,Fowler Carla,Casamina Chanel C.,Georgopolos Christina M.,McAfee Megan S.,Schmitt Thomas M.,Tan Xiaoxia,Kim Tae-Don,Choi Inpyo,Blattman Joseph N.,Greenberg Philip D.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference86 articles.

1. Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma

2. Adoptive-cell-transfer therapy for the treatment of patients with cancer

3. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

4. Adoptive cell transfer: a clinical path to effective cancer immunotherapy

5. T Cell Receptor Gene Therapy for Cancer

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein tyrosine phosphatases as emerging targets for cancer immunotherapy;British Journal of Pharmacology;2024-01-17

2. CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides;Nature Immunology;2023-11-09

3. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data;Frontiers in Oncology;2023-10-31

4. CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro;Experimental Hematology & Oncology;2023-10-06

5. Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets;Journal for ImmunoTherapy of Cancer;2023-05